At a House Foreign Affairs Committee hearing before the Congressional recess, Deputy Secretary of State for Management and Resources Michael Rigas responded to a question from Rep. Thomas Kean, Jr. about the use of American pharmaceuticals in foreign emergency health programs.<br />
